E-viri
PDF
Recenzirano
Odprti dostop
-
Budde, Lihua E.; Zaia, John A.
Blood, 01/2018, Letnik: 131, Številka: 1Journal Article
In this issue of Blood, Hill and colleagues characterized infectious complications in patients with relapsed or refractory B-cell malignancies after treatment with CD19-targeted chimeric antigen receptor–modified T (CAR-T) cells in a phase 1/2 study.1 This is the first study that systemically analyzed infectious events in CAR–T-cell–treated patients.
